Consumption of Bovine Spongiform Encephalopathy (BSE) Contaminated Beef and the Risk of Variant Creutzfeldt‐Jakob Disease

To date, the variant Creutzfeldt‐Jakob disease (vCJD) risk assessments that have been performed have primarily focused on predicting future vCJD cases in the United Kingdom, which underwent a bovine spongiform encephalopathy (BSE) epidemic between 1980 and 1996. Surveillance of potential BSE cases was also used to assess vCJD risk, especially in other BSE‐prevalent EU countries. However, little is known about the vCJD risk for uninfected individuals who accidentally consume BSE‐contaminated meat products in or imported from a country with prevalent BSE. In this article, taking into account the biological mechanism of abnormal prion PrPres aggregation in the brain, the probability of exposure, and the expected amount of ingested infectivity, we establish a stochastic mean exponential growth model of lifetime exposure through dietary intake. Given the findings that BSE agents behave similarly in humans and macaques, we obtained parameter estimates from experimental macaque data. We then estimated the accumulation of abnormal prions to assess lifetime risk of developing clinical signs of vCJD. Based on the observed number of vCJD cases and the estimated number of exposed individuals during the BSE epidemic period from 1980 to 1996 in the United Kingdom, an exposure threshold hypothesis is proposed. Given the age‐specific risk of infection, the hypothesis explains the observations very well from an extreme‐value distribution fitting of the estimated BSE infectivity exposure. The current BSE statistics in the United Kingdom are provided as an example.

[1]  M. Arnold,et al.  Pathogenesis of experimental bovine spongiform encephalopathy (BSE): estimation of tissue infectivity according to incubation period§ , 2008, Veterinary research.

[2]  H. Laude,et al.  Prion agent diversity and species barrier. , 2008, Veterinary research.

[3]  F. V. van Zijderveld,et al.  TSE pathogenesis in cattle and sheep. , 2008, Veterinary research.

[4]  Arie H. Havelaar,et al.  The future of BSE Risk Assessments , 2007 .

[5]  Aline A. De Koeijer Analyzing BSE Transmission to Quantify Regional Risk , 2007 .

[6]  Didier Calavas,et al.  Complementary Approach of Data Analysis and Modeling to Estimate the Pattern of the BSE Epidemic: The Example of France , 2007, Risk analysis : an official publication of the Society for Risk Analysis.

[7]  A. D. de Koeijer,et al.  Quantitative Risk Assessment for Bovine Spongiform Encephalopathy in Low‐ or Zero‐Prevalence Countries: The Example of Norway , 2007, Risk analysis : an official publication of the Society for Risk Analysis.

[8]  A. D. de Koeijer Analyzing BSE Transmission to Quantify Regional Risk , 2007, Risk analysis : an official publication of the Society for Risk Analysis.

[9]  N. Speybroeck,et al.  Trends in age at detection in cases of bovine spongiform encephalopathy in Belgium: an indicator of the epidemic curve , 2006, Veterinary Record.

[10]  P. Gale BSE risk assessments in the UK: a risk tradeoff? , 2006, Journal of applied microbiology.

[11]  J Collinge,et al.  Molecular neurology of prion disease , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[12]  E. Grist Transmissible Spongiform Encephalopathy Risk Assessment: The UK experience , 2005, Risk analysis : an official publication of the Society for Risk Analysis.

[13]  F. Mouthon,et al.  Risk of oral infection with bovine spongiform encephalopathy agent in primates , 2005, The Lancet.

[14]  L. Schonberger,et al.  The public health impact of prion diseases. , 2005, Annual review of public health.

[15]  P. Comer,et al.  Exposure of the human population to BSE infectivity over the course of the BSE epidemic in Great Britain and the impact of changes to the Over Thirty Month Rule , 2004 .

[16]  D. Dormont,et al.  Tissue distribution of bovine spongiform encephalopathy agent in primates after intravenous or oral infection , 2004, The Lancet.

[17]  R. Curnow,et al.  Repeated challenge with prion disease: The risk of infection and impact on incubation period , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Christl A Donnelly,et al.  Assessment of the risk posed by bovine spongiform encephalopathy in cattle in Great Britain and the impact of potential changes to current control measures , 2003, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[19]  S. Norley,et al.  Prion diseases: infectious and lethal doses following oral challenge. , 2003, The Journal of general virology.

[20]  A. Ghani,et al.  Short-term projections for variant Creutzfeldt-Jakob disease onsets , 2003, Statistical methods in medical research.

[21]  S. Cousens,et al.  The predictability of the epidemic of variant Creutzfeldt-Jakob disease by back-calculation methods , 2003, Statistical methods in medical research.

[22]  R. Kulkarni,et al.  Theoretical modeling of prion disease incubation. , 2001, Biophysical journal.

[23]  A. Bouma,et al.  Factors that influence the age distribution of BSE cases: potentials for age targeting in surveillance , 2002 .

[24]  A. Ghani,et al.  The transmission dynamics of BSE and vCJD. , 2002, Comptes rendus biologies.

[25]  Cooper Jd,et al.  UK dietary exposure to BSE in beef mechanically recovered meat: by birth cohort and gender. , 2002 .

[26]  S. Bird,et al.  UK dietary exposure to BSE in beef mechanically recovered meat: by birth cohort and gender. , 2002, Journal of cancer epidemiology and prevention.

[27]  A. Valleron,et al.  Estimation of Epidemic Size and Incubation Time Based on Age Characteristics of vCJD in the United Kingdom , 2001, Science.

[28]  S. Cousens,et al.  Predictability of the UK Variant Creutzfeldt-Jakob Disease Epidemic , 2001, Science.

[29]  K. McDonnell,et al.  Predictive modelling and risk assessment of BSE: a review , 2001 .

[30]  J. Hauw,et al.  Adaptation of the bovine spongiform encephalopathy agent to primates and comparison with Creutzfeldt– Jakob disease: Implications for human health , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[31]  A. McLean,et al.  Scrapie infections initiated at varying doses: an analysis of 117 titration experiments. , 2000, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[32]  Christl A. Donnelly,et al.  Predicted vCJD mortality in Great Britain , 2000, Nature.

[33]  M. Williams,et al.  Risk of transmission of bovine spongiform encephalopathy to humans in the United States: report of the Council on Scientific Affairs. American Medical Association. , 1999, JAMA.

[34]  P. Gale Quantitative BSE risk assessment: relating exposures to risk , 1998, Letters in applied microbiology.

[35]  R. Anderson,et al.  Estimation of the number of people incubating variant CJD , 1998, The Lancet.

[36]  N M Ferguson,et al.  The epidemiology of BSE in cattle herds in Great Britain. II. Model construction and analysis of transmission dynamics. , 1997, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[37]  C. Donnelly,et al.  Transmission dynamics and epidemiology of BSE in British cattle , 1997, Nature.

[38]  R. G. Will,et al.  Predicting the CJD epidemic in humans , 1997, Nature.

[39]  J. Hauw,et al.  BSE transmission to macaques , 1996, Nature.

[40]  Sheldon M. Ross,et al.  Stochastic Processes , 2018, Gauge Integral Structures for Stochastic Calculus and Quantum Electrodynamics.